Immune checkpoint inhibitor-associated sarcoidosis reaction
Immune checkpoint inhibitors (ICIs) constitute a class of drugs that stimulate the immune system to fight cancer cells. However, they can also induce immune-related adverse events (irAEs) in various organs, including the kidneys. One of the infrequent irAEs associated with ICIs is sarcoidosis, an in...
Main Authors: | Parisa Keshtgar, Parisa Kaviani, Payam Peymani, Neda Kianpour, Samin Karamian |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Diabetic Nephropathy Prevention
2023-09-01
|
Series: | Journal of Nephropathology |
Subjects: | |
Online Access: | https://nephropathol.com/PDF/jnp-12-e21520.pdf |
Similar Items
-
Sarcoidosis and Airway Disease After Immune Checkpoint Inhibitor Therapy: Case Study and Review of the Literature
by: Felipe Soto, et al.
Published: (2023-05-01) -
Imaging Changes and Immune-Checkpoint Expression on T Cells in Bronchoalveolar Lavage Fluid from Patients with Pulmonary Sarcoidosis
by: Yasuaki Kotetsu, et al.
Published: (2021-09-01) -
The Relationship between Tumor Development and Sarcoidosis in Aspects of Carcinogenesis before and after the Onset of Sarcoidosis
by: Yoshimasa Hachisu, et al.
Published: (2022-06-01) -
Renal Sarcoidosis-like Reaction Induced by PD-1 Inhibitor Treatment in Non-Small Cell Lung Cancer: A Case Report and Literature Review
by: Sang-Don Park, et al.
Published: (2023-05-01) -
Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma
by: Mathew R. Birnbaum, BS, et al.
Published: (2017-05-01)